Free Nikkei 500 Pharmaceuticals (NG08.OS) Technical Analysis Signals

Overal Signal
Buy
Last Update / Period
19 Aug / Daily
Category/Currency
Indexes/JPY
Exchange/Country
OSA/--

Nikkei 500 Pharmaceuticals (NG08.OS) signal with technical analysis on 19 Aug

On 19 Aug, we conducted a comprehensive technical analysis of Nikkei 500 Pharmaceuticals (NG08.OS), considering 99 signals with intricate details. Here are the key findings: 27 signals suggested buy strategies, while 2 indicated sell strategies. The remaining 70 signals remained neutral without offering a specific direction.

DEMA 1DEMA 2DEMA 3KAMA 2KAMA 3KAMA 4WMA Crossover 2MIDPOINT Slope 1MIDPOINT Slope 2T3 Slope 1TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 1SAR CrossoverMOM Crossover 1PLUS_DI Threshold 1PLUS_DI Threshold 2ROC Threshold 1ROC Threshold 2ROCR Threshold 2ROCR Threshold 3WILLR Exit OversoldWILLR Exit OverboughtBOP Smoothed ThresholdMACD Crossover 1MACD Crossover 2Daily Pivot Point 1CMO Divergence 1

Belt-hold Closing Marubozu Long Line Candle Marubozu Separating Lines

Overall Strategy:
Buy Signals: 27
Sell Signals: 2
Neutral Signals: 70
Result: This strategy leads to a Buy position.

Disclaimer! Please exercise caution and thorough consideration before making any financial decisions. It's important to note that our signals are based solely on daily price changes and do not take into account external factors such as news, market sentiment, or company developments. We strongly recommend considering all relevant factors and conducting your own research.

Useful Tips: To make the most informed decisions about your Nikkei 500 Pharmaceuticals (NG08.OS) investments, we highly recommend visiting the "magicalprediction" AI models signals website. They provide free signals, and if one aligns with ours, it is likely to be a reliable indicator, as we have observed over time.


Result: Looking at the technical analysis for Nikkei 500 Pharmaceuticals (NG08.OS) on , there seems to be a tendency toward a buy signal based on historical data and analysis. However, it's important to remember that these signals are not guarantees, and any investment decision should be made carefully. Consider the overall market conditions and how your choices align with your specific investment goals.


Based on the above signals, we recommend the following strategies:

Nikkei 500 Pharmaceuticals (NG08.OS) trading strategy for those in buy positions (long positions): If you are currently in a buy (long) position, holding your position may be a good strategy according to our signals. However, always exercise caution and monitor market developments closely.

Nikkei 500 Pharmaceuticals (NG08.OS) trading strategy for those in sell positions (short positions): If you are currently in a sell (short) position, it is recommended to choose the optimal time to exit based on our signal combination. If you have a higher risk tolerance, consider waiting for market movements in the coming days.

For new positions: If you are not currently in the market or are considering switching to a buy (long) position, it’s advisable to consider the projected price range. This range represents a potential upside of 9.22%, determined by the highest predicted price. However, before deciding to enter a buy position, be cautious and conduct thorough research to ensure it aligns with your risk tolerance and investment goals.

In all your trading endeavors, implementing a well-defined stop-loss strategy is crucial for managing potential downside risks effectively.

Useful Tip 2: For those interested in long-term forecasting, we suggest utilizing the "predict-price" website, which offers both short-term and long-term predictions for free. This can help you make more informed decisions regarding your **Nikkei 500 Pharmaceuticals (NG08.OS)** holdings.

Nikkei 500 Pharmaceuticals (NG08.OS) Price Analysis and Resistance Levels:

Given our current long position in Nikkei 500 Pharmaceuticals (NG08.OS), analyzing key resistance levels is crucial to better understand its price movement. These levels are important benchmarks for our strategy, and we will explore multiple scenarios to provide a comprehensive outlook.

First resistance level (8053.04): The primary hurdle we face is the 8053.04 price level. If the current trend remains unchanged, Nikkei 500 Pharmaceuticals (NG08.OS) could break above this level, signaling its strength and potential for further growth.

Second resistance level (8576.92): If the upward trend continues with significant strength, we may see Nikkei 500 Pharmaceuticals (NG08.OS) cross the second resistance level at 8576.92, indicating a major upside move and a promising direction for our position.

Third resistance level (9026.1): For a more comprehensive analysis, consider a scenario where Nikkei 500 Pharmaceuticals (NG08.OS) not only breaks the second resistance level but holds its price above this mark. If this trend continues in the coming days, Nikkei 500 Pharmaceuticals (NG08.OS) could potentially reach the third resistance level of 9026.1.
It's essential to closely monitor these resistance levels and consider them in the broader context of market trends and indicators. To make informed decisions when trading Nikkei 500 Pharmaceuticals (NG08.OS), stay alert and continually analyze the market. By focusing on these resistance levels and considering broader market dynamics, you can make smarter trading decisions and adapt to this dynamic market.

Nikkei 500 Pharmaceuticals (NG08.OS) technical analysis chart

Nikkei 500 Pharmaceuticals (NG08.OS) support and resistance levels

Name Level1 Level2 Level3 Level4 Level5
Resistance 8053.04 8576.92 9026.1 9159.78 --
Support 7646.22 7148.6 6880.94 -- --
 Nikkei 500 Pharmaceuticals (NG08.OS) Support and Resistance area (19 Aug)  Nikkei 500 Pharmaceuticals (NG08.OS) Support and Resistance area (19 Aug)

Nikkei 500 Pharmaceuticals (NG08.OS) signals list for 19 Aug

Overall Signals

Nikkei 500 Pharmaceuticals (NG08.OS) candlestick patterns on 19 Aug

Today's Nikkei 500 Pharmaceuticals (NG08.OS) Candle Patterns List:

Belt-hold Closing Marubozu Long Line Candle Marubozu Separating Lines

Nikkei 500 Pharmaceuticals (NG08.OS) technical analysis over the past days

# Date Overal Signals ALL Signals
1 19 Aug B KAMA 3KAMA 4EMA Crossover 1MIDPOINT Slope 2TEMA Price 2TEMA Price 3PLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 1TRIX Crossover 2BOP Smoothed ThresholdCMO Divergence 1
2 18 Aug B EMA Price Cross 1EMA Price Cross 2EMA Price Cross 4KAMA 4WMA Crossover 1MIDPOINT Slope 2T3 Slope 1TEMA Price 1TEMA Price 3PLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 3STOCH Normal Zone CrossStochastic RSI SignalPercentage Price Oscillator
3 15 Aug B DEMA 2EMA Price Cross 1EMA Price Cross 2EMA Price Cross 4KAMA 1KAMA 4MIDPOINT Slope 1T3 Slope 1TEMA Price 2TEMA Price 3TRIMA Slope 1MOM Crossover 1PLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 1BOP Smoothed ThresholdMACD Crossover 2Engulfing PatternDaily Pivot Point 1
4 14 Aug S EMA Price Cross 1EMA Price Cross 2EMA Price Cross 4KAMA 3KAMA 4MIDPOINT Slope 1TEMA Price 1TEMA Price 3TRIMA Slope 1PLUS_DI Threshold 1PLUS_DI Threshold 2TRIX Crossover 1BOP Smoothed ThresholdStochastic RSI Signal
5 13 Aug B DEMA 2EMA Price Cross 3KAMA 1KAMA 4WMA Crossover 2TEMA Price 2TEMA Price 3TRIMA Slope 3MOM Crossover 1PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdIchimoku 3
6 12 Aug N DEMA 1DEMA 2DEMA 3EMA Price Cross 1EMA Price Cross 2EMA Price Cross 3EMA Price Cross 4KAMA 1KAMA 2EMA Crossover 1WMA Crossover 1MIDPOINT Slope 1MIDPOINT Slope 2TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 3SAR CrossoverCCI Crossover 1CCI Crossover 2CCI Crossover 3MOM Crossover 1PLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 1RSI Exit OversoldRSI Exit OverboughtWILLR Exit OversoldMACD Crossover 1STOCH Normal Zone CrossStochastic RSI SignalDaily Pivot Point 1CMO Divergence 1
7 08 Aug S DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 1MIDPOINT Slope 4TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3CMO Crossover 1PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdMACD Crossover 1STOCH Normal Zone CrossDonchian ChannelDaily Pivot Point 1CMO Divergence 1
8 07 Aug B DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4WMA Crossover 1MIDPOINT Slope 3MIDPOINT Slope 4TEMA Price 1TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 1WILLR Exit OversoldBOP Smoothed ThresholdKeltner Channel 1Daily Pivot Point 1CMO Divergence 1
9 06 Aug B EMA Price Cross 4KAMA 2KAMA 3KAMA 4WMA Crossover 1MIDPOINT Slope 3TEMA Price 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2WILLR Exit OverboughtBOP Smoothed ThresholdStochastic RSI SignalDaily Pivot Point 1
10 05 Aug B DEMA 1EMA Price Cross 4KAMA 2KAMA 3KAMA 4TEMA Price 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3CCI Crossover 1CCI Crossover 2PLUS_DI Threshold 1PLUS_DI Threshold 2RSI Exit OversoldBOP Smoothed ThresholdMACD Crossover 1CMO Divergence 1
11 04 Aug N DEMA 3KAMA 2KAMA 3KAMA 4TRIMA Slope 2TRIMA Slope 3CCI Crossover 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdStochastic RSI Signal
12 01 Aug B DEMA 3KAMA 2KAMA 3KAMA 4MIDPOINT Slope 4T3 Slope 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3CMO Crossover 1PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdDonchian ChannelCMO Divergence 1
13 31 Jul B DEMA 3KAMA 2KAMA 3KAMA 4MIDPOINT Slope 2T3 Slope 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdKeltner Channel 1Donchian ChannelDaily Pivot Point 1CMO Divergence 1
14 30 Jul B DEMA 3KAMA 2KAMA 3KAMA 4EMA Crossover 4MIDPOINT Slope 2T3 Slope 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3CCI Crossover 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdCMO Divergence 1
15 29 Jul B DEMA 2DEMA 3KAMA 2KAMA 3KAMA 4WMA Crossover 4T3 Slope 1T3 Slope 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3AROONOSC 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdBBANDS Breakout 2CMO Divergence 1
16 28 Jul B DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 1T3 Slope 1T3 Slope 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdCMO Divergence 1
17 25 Jul B DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 3MIDPOINT Slope 4T3 Slope 1T3 Slope 2TEMA Price 2TEMA Price 3TRIMA Slope 2PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdSTOCH Normal Zone CrossKeltner Channel 1Donchian ChannelDaily Pivot Point 1CMO Divergence 1
18 24 Jul B DEMA 1DEMA 2DEMA 3EMA Price Cross 1EMA Price Cross 2EMA Price Cross 3EMA Price Cross 4KAMA 1KAMA 2KAMA 3EMA Crossover 1EMA Crossover 3WMA Crossover 1MIDPOINT Slope 2MIDPOINT Slope 3MIDPOINT Slope 4T3 Slope 2TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 2MOM Crossover 2PLUS_DI Threshold 1PLUS_DI Threshold 2ROC Threshold 1ROC Threshold 2ROCR Threshold 1ROCR Threshold 2ROCR Threshold 3ROCR Threshold 4WILLR Exit OversoldWILLR Exit OverboughtBOP Smoothed ThresholdBBANDS Breakout 1Stochastic RSI SignalDonchian ChannelIchimoku 1Ichimoku 2Ichimoku 3Daily Pivot Point 1CMO Divergence 1Coppock Curve
19 23 Jul B DEMA 1EMA Price Cross 1EMA Price Cross 2EMA Price Cross 3EMA Price Cross 4KAMA 1KAMA 4EMA Crossover 1WMA Crossover 1TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2CCI Crossover 1CCI Crossover 2CCI Crossover 3PLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 4BOP Smoothed ThresholdSTOCH Normal Zone CrossBBANDS Breakout 1Ichimoku 2Ichimoku 3CMO Divergence 1
20 22 Jul S DEMA 3T3 Slope 1TEMA Price 3TRIMA Slope 1TRIMA Slope 2AROONOSC 2AROONOSC 4MOM Crossover 2PLUS_DI Threshold 1PLUS_DI Threshold 2RSI Exit OversoldBOP Smoothed ThresholdStochastic RSI SignalPercentage Price OscillatorSchaff Trend Cycle
21 18 Jul B DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2WMA Crossover 3MIDPOINT Slope 1MIDPOINT Slope 2MIDPOINT Slope 3T3 Slope 1TEMA Price 2TEMA Price 3TRIMA Slope 1MOM Crossover 2PLUS_DI Threshold 1PLUS_DI Threshold 2ROC Threshold 1ROCR Threshold 2TRIX Crossover 2WILLR Exit OversoldWILLR Exit OverboughtBOP Smoothed ThresholdIchimoku 2Daily Pivot Point 1CMO Divergence 1
22 17 Jul B DEMA 2EMA Price Cross 3KAMA 4EMA Crossover 2MIDPOINT Slope 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 3MOM Crossover 1PLUS_DI Threshold 1PLUS_DI Threshold 2TRIX Crossover 1BOP Smoothed ThresholdBBANDS Breakout 1CMO Divergence 1
23 16 Jul B DEMA 2DEMA 3KAMA 4MIDPOINT Slope 1MIDPOINT Slope 2TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 3SAR CrossoverPLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 1BOP Smoothed ThresholdMACD Crossover 2Vortex IndicatorCMO Divergence 1
24 15 Jul B DEMA 1DEMA 2EMA Price Cross 1EMA Price Cross 2KAMA 3KAMA 4EMA Crossover 1WMA Crossover 2MIDPOINT Slope 3TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3AROONOSC 1AROONOSC 3PLUS_DI Threshold 1PLUS_DI Threshold 2ROC Threshold 1BOP Smoothed ThresholdCMO Divergence 1
25 14 Jul B DEMA 1DEMA 2EMA Price Cross 4KAMA 2KAMA 3KAMA 4WMA Crossover 1MIDPOINT Slope 1TEMA Price 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3CCI Crossover 1CCI Crossover 2PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdMACD Crossover 1CMO Divergence 1
26 11 Jul B KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 4TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3BOP Smoothed ThresholdSTOCH Normal Zone CrossStochastic RSI Signal
27 10 Jul S DEMA 1KAMA 1KAMA 2KAMA 3KAMA 4T3 Slope 1T3 Slope 2TEMA Price 1TEMA Price 2TRIMA Slope 1TRIMA Slope 2CCI Crossover 3RSI Exit OversoldBOP Smoothed ThresholdBBANDS Breakout 2Stochastic RSI Signal
28 09 Jul N DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 1MIDPOINT Slope 2MIDPOINT Slope 3MIDPOINT Slope 4T3 Slope 1T3 Slope 2TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2AROONOSC 3PLUS_DI Threshold 1ROC Threshold 1BOP Smoothed ThresholdSTOCH Normal Zone CrossKeltner Channel 1Donchian ChannelCMO Divergence 1
29 08 Jul S DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 2MIDPOINT Slope 4T3 Slope 1T3 Slope 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2ROCR Threshold 2ROCR Threshold 4WILLR Exit OversoldWILLR Exit OverboughtBOP Smoothed ThresholdDaily Pivot Point 1CMO Divergence 1
30 07 Jul S DEMA 3KAMA 2KAMA 3KAMA 4T3 Slope 1TEMA Price 3TRIMA Slope 1RSI Exit OversoldBOP Smoothed ThresholdHammer / Hanging Man

Users forecasts for Nikkei 500 Pharmaceuticals (NG08.OS)

What is your prediction?

In this section, you can easily predict without user registration. See also other users predictions.

What is your prediction?

Nikkei 500 Pharmaceuticals (NG08.OS) predictions by visitors

Please fill in your email
Please fill in your Text
CAPTCHA Image
Please fill in your Captcha

Comments